更新2024年乳腺癌第二部分 - 早期乳腺癌患者
Wolfgang Janni1, Hans-Christian Kolberg2, Andreas D Hartkopf3
1Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
Geburtshilfe und Frauenheilkunde
|May 19, 2025
概括
早期乳腺癌的新疗法包括针对三阴性乳腺癌 (TNBC) 的免疫检查点抑制剂和针对高危激素受体阳性瘤的CDK4/6抑制剂. 生物标志物研究,如循环瘤DNA (ctDNA),也在推进治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 翻译医学是一种翻译医学.
背景情况:
- 乳腺癌早期治疗已经取得了重大进展.
- 关键的进展集中在特定的亚型,如三阴性乳腺癌 (TNBC) 和激素受体阳性,HER2-阴性 (HRpos/HER2neg) 瘤,具有高复发风险.
研究的目的:
- 审查乳腺癌早期治疗的最新临床进展.
- 将最近研究的发现与长期后续数据和转化分析联系起来.
主要方法:
- 关于早期乳腺癌治疗的最新出版物的文献综述.
- 对临床试验数据和翻译研究结果的分析.
主要成果:
- 免疫检查点抑制剂在治疗TNBC方面表现有前途.
- CDK4/6抑制剂对具有高复发风险的HRpos/HER2neg瘤有效.
- 新兴的生物标志物,包括循环瘤DNA (ctDNA),正在被整合到患者分层和监测中.
结论:
- 最近的进展为特定的早期乳腺癌亚型提供了改进的治疗选择.
- 长期随访数据和生物标志物研究对于完善治疗策略和了解患者结果至关重要.
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Cancer Vaccines
310
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310


